Kisspeptin-10

INVESTIGATIONAL

Reproductive axis activator | Libido and fertility

By the INFOPEPTIDOS editorial team · content based on scientific literature.

Updated: August 2026.

Kisspeptin-10 — Active fragment of the kisspeptin peptide, master regulator of the reproductive axis. It is mainly researched for libido, fertility and reproductive hormonal activation. Typical dose: 50–100 mcg, subcutaneous, per the research protocol. Not FDA-approved (research compound).
Typical dose
50-100 mcg
Per protocol
Route
Injectable
Subcutaneous
Cycle
In cycles
Typical duration
Storage
2-8 °C
Refrigerated

Key points

Technical data: Molecular formula C63H83N17O14 · Molecular weight 1302.4 g/mol. Source: PubChem.

Overview

What is kisspeptin-10?

Kisspeptin-10 is the active fragment of kisspeptin, a peptide that acts as the 'master switch' of the reproductive axis. It sits at the top of the hormonal cascade: it stimulates the neurons that release GnRH and, with it, the entire signal toward the pituitary and gonads. It is researched for its effects on libido and fertility.

Key benefits

It physiologically activates the reproductive axis, with possible effects on sexual desire and as a fertility tool. Unlike more direct stimuli, it respects natural regulation by acting at the highest point of the cascade.

Mechanism of action

It binds KISS1R receptors on hypothalamic GnRH neurons and activates them. This triggers the release of GnRH and, in cascade, LH and FSH, and finally sex hormones. It is the initial step of the reproductive axis.

Quick start guide

Typical dose
50-100 mcg
Frequency
Per protocol
Where to inject
Subcutaneous (abdomen)
Timing
As indicated
Effects timeline
Fast hormonal response; variable libido
Storage
Refrigerate at 2-8 °C
Cycle length
In cycles
Common combination
In fertility/hormonal protocols

Dosing protocol

PhaseDoseRouteDuration
Standard50–100 mcgSubcutaneousIn cycles

Doses and regimens come from research studies and vary widely. The regimen must be set by a healthcare professional.

Reconstitution: units in the syringe

Example with a 5 mg vial + 2 ml of bacteriostatic water → a 2.5 mg/ml solution. On a U-100 insulin syringe (100 units = 1 ml):

DoseVolumeUnits (U-100)
50 mcg0.02 ml2 U
100 mcg0.04 ml4 U

Is your vial or water different? Calculate the exact units below.

🧮 Calculate your exact syringe dose →

Kisspeptin-10 vs Gonadorelin

 Kisspeptin-10Gonadorelin
Level of actionHypothalamus (upstream)Pituitary
EffectStimulates natural GnRHReleases LH/FSH directly
Typical useLibido and fertilityTRT support and fertility
RegulationVery physiologicalDirect

⚠️ Who should NOT use it

What to expect

Side effects & safety

Frequently asked questions

What is kisspeptin-10?

It is the active fragment of kisspeptin, the master regulator of the reproductive axis that activates GnRH neurons.

What is kisspeptin-10 used for?

It is researched for libido, fertility and physiological activation of the reproductive hormonal axis.

How does it differ from gonadorelin?

Kisspeptin acts upstream (in the hypothalamus, on GnRH); gonadorelin acts on the pituitary.

What is the kisspeptin-10 dose?

Around 50-100 mcg subcutaneously, per research protocols. The regimen is set by a professional.

What are the side effects?

It is usually very well tolerated; mild injection reaction and variable response.

Is kisspeptin-10 approved?

No; it is a research compound not approved by the FDA.

Research areas

Related peptides

Related articles

Related topics

Summary

What it is: Active fragment of kisspeptin.

How it is researched: Subcutaneous, 50-100 mcg, in cycles.

Key features: Activates the reproductive axis upstream. Not FDA-approved.

Related peptides: Gonadorelin, PT-141 and Oxytocin.

References

  1. Li Z et al. (2024). Kisspeptin-10 binding to Gpr54 in osteoclasts prevents bone loss by activating Dusp18-mediated dephosphorylation of Src. Nat Commun. PubMed · DOI
  2. Navarro VM (2020). Metabolic regulation of kisspeptin - the link between energy balance and reproduction. Nat Rev Endocrinol. PubMed · DOI
  3. Abreu AP et al. (2016). Pubertal development and regulation. Lancet Diabetes Endocrinol. PubMed · DOI
  4. Radwańska P et al. (2023). Kisspeptin-10 increases collagen content in the myocardium by focal adhesion kinase activity. Sci Rep. PubMed · DOI

Studies compiled from PubMed for informational purposes; many are preclinical or research-stage and do not constitute medical advice.